Hypersensitivity pneumonitis (HP) is a complex and heterogeneous interstitial lung disease
(ILD) that occurs when susceptible individuals develop an exaggerated immune response to …

Hypersensitivity pneumonitis is an immune‐mediated interstitial lung disease caused by an
aberrant response to an inhaled exposure, which results in mostly T cell–mediated …

Recent clinical practice guidelines have addressed the diagnosis of idiopathic pulmonary
fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP). These disease-specific …

Millions of workers are exposed to substances known to cause occupational interstitial lung
diseases (ILDs), particularly in developing countries. However, the burden of the disease is …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–
induced coronavirus disease (COVID-19) dominated the year 2020. Initial reports of the long …

Hypersensitivity pneumonitis (HP) is one of the most common interstitial lung diseases (ILD),
that presents unique challenges for a confident diagnosis and limited therapeutic options …

The COVID-19 pandemic has affected people from almost every walk of life in general and
academia in particular. It had a huge impact on teaching and learning resulting in a sudden …

Considering recently published two guidelines for the diagnosis of hypersensitivity
pneumonitis (HP), the Japanese Respiratory Society (JRS) has now published its own …

Inhalational exposures are increasingly recognized as an important component in the
development of ILDs, and novel exposure-disease associations continue to be discovered …

Interstitial lung diseases (ILDs) are a heterogeneous group of parenchymal lung diseases,
some of which arise as a result of genetic susceptibility, as well as external noxious stimuli …